Patents by Inventor Xiadong REN

Xiadong REN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210309616
    Abstract: Small molecule inhibitors are claimed that selectively target the hemopexin domain of matrix metalloproteinase 9 (MMP-9) and do not inhibit the protease's catalytic functions. A method of treating cancer in a patient in need thereof with the compounds of the invention is also claimed.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 7, 2021
    Inventors: Iwao OJIMA, Vincent ALFORD, Anushree KAMATH, Jian CAO, Xiadong REN, Nicole SAMPSON, Monaf AWWA
  • Patent number: 11040947
    Abstract: A compound of Formula I: wherein: Y is —C(O)NHR1 or —NHC(O)R1; R1 is aryl; ?is ?optionally substituted with one or more substituents selected from the group consisting of oxo, F, Cl, Br, I, alkyl, NH2, NHR4, NHC(O)R4, NHC(O)OR4, NR5R6, OH, OR4, SR4, cycloalkyl and aryl; or ?is ?optionally substituted with one or more substituents selected from the group consisting of F, Cl, Br, I, CN, NO2, alkyl, C(O)R4, C(O)NHR4, C(O)NR5R6, C(O)OH, C(O)OR4, NH2, NHR4, NHC(O)OR4, NR5R6, OH, OR4, SR4, cycloalkyl and aryl; each R4 is independently alkyl, cycloalkyl, or aryl; each R5 is independently alkyl, cycloalkyl, or aryl; each R6 is independently alkyl, cycloalkyl, or aryl; or each R5 and R6, together with the nitrogen atom to which they are attached, independently form an unsubstituted heterocyclic alkyl or unsubstituted heterocyclic aryl; and X is —S— or —O—; and n is 2, 3, or 4.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: June 22, 2021
    Assignee: The Research Foundation for The State University of New York
    Inventors: Iwao Ojima, Vincent Alford, Anushree Kamath, Jian Cao, Xiadong Ren, Nicole Sampson, Monaf Awwa
  • Publication number: 20200017452
    Abstract: Small molecule inhibitors are claimed that selectively target the hemopexin domain of matrix metalloproteinase 9 (MMP-9) and do not inhibit the protease's catalytic functions. A method of treating cancer in a patient in need thereof with the compounds of the invention is also claimed.
    Type: Application
    Filed: March 22, 2018
    Publication date: January 16, 2020
    Inventors: Iwao OJIMA, Vincent ALFORD, Anushree KAMATH, Jian CAO, Xiadong REN, Nicole SAMPSON, Monaf AWWA